Posted by ABMN Staff on May 15th, 2024
Equities researchers at TD Cowen initiated coverage on shares of Biodesix (NASDAQ:BDSX – Get Free Report) in a report released on Monday, Marketbeat Ratings reports. The firm set a “buy” rating and a $2.80 price target...
More of this article »